Novo Nordisk Walks Away from $10 Billion Fight--And the Stock Rallies Anyway

Pfizer wins Metsera after antitrust warning derails Novo's $9B bid; investors reward financial discipline over deal chasing.

Trump rolls out pricing deal with weight-loss-drug giants Eli Lilly, Novo Nordisk. Analysts say the pact raises more questions than it answers.

The Trump administration on Thursday rolled out a much-anticipated deal with drugmakers Eli Lilly and Novo Nordisk that aims ...

Novo Nordisk ropes in Emcure Pharma to roll out weight loss drug Poviztra

Danish drugmaker Novo Nordisk announced a partnership with Emcure Pharma on Monday to launch its Poviztra, semaglutide injection 2.4 mg, in India. Poviztra is the second brand of its weight loss drug ...

Novo Nordisk: Hold On Tightly As The Market Tests Your Faith

Novo Nordisk navigates competition and guidance challenges with strong profitability and upcoming oral Wegovy opportunities.
PolitiFact

Novo Nordisk's Gordon Findlay didn't faint Nov. 6, 2025, in the Oval Office. He wasn't even there

Gordon Findlay is a Novo Nordisk manager based in Switzerland who didn’t attend the White House’s Nov. 6 drug pricing announcement. Robert F. Kennedy Jr. wasn’t fleeing the scene, a White House ...
FOX 11 Los Angeles

Dr. Oz jumps in as drug exec collapses during Oval Office press conference

A drug executive collapsed in the Oval Office while President Donald Trump was announcing a deal with drugmakers to reduce ...
Fierce Pharma

Novo forges partnership with Emcure to expand Wegovy access in India

Just five months after Novo Nordisk launched Wegovy in India, the Danish company has partnered (PDF) with Emcure ...

Novo Nordisk's Wegovy® (semaglutide 2.4 mg) was associated with liver health-related benefits not solely based on weight loss in adult patients with MASH with liv…

Novo Nordisk today presented data at the 76th annual American Association for the Study of Liver Diseases (AASLD) meeting, ...